<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001635'>Heart failure</z:hpo> and <z:mp ids='MP_0002055'>diabetes</z:mp> are <z:hpo ids='HP_0011010'>chronic</z:hpo> conditions that frequently concur in the same patient </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DM2</z:e> is a known risk factor for the development of <z:hpo ids='HP_0001635'>heart failure</z:hpo> and is related with a worse outcome </plain></SENT>
<SENT sid="2" pm="."><plain>Some studies have found that <z:hpo ids='HP_0001635'>heart failure</z:hpo> is also associated with a greater incidence of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>This relationship has been less studied and the mechanisms underneath this association are not fully understood </plain></SENT>
<SENT sid="4" pm="."><plain>We have done a review of the literature in search for studies that evaluate the relationship between <z:hpo ids='HP_0001635'>heart failure</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, as well as the possible mechanisms leading to this situation, such as sympathetic hyperactivation, increased concentration of free fatty acids and adiponectin resistance </plain></SENT>
</text></document>